There are several treatment regimens recommended in the United States for TB disease. TB treatment can take 4, 6, or 9 months depending on the regimen. TB treatment regimens include

NEW4-month Rifapentine-moxifloxacin TB Treatment Regimen

Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022. MMWR Morb Mortal Wkly Rep, 2022

- - Frequently Asked Questions (FAQs) on a 4-month rifapentine-moxifloxacin TB treatment regimen
6- or 9-month RIPE TB Treatment Regimen
- Treatment of Drug-Susceptible Tuberculosisexternal icon. Clin Infect Dis, 2016
  - Table 3. Doses of Antituberculosis Drugs for Adults and Childrenexternal icon
    Note: this table is an excerpt from Treatment of Drug-Susceptible Tuberculosisexternal icon and cites supporting information available in the complete guidelines.
  - Highlights from the 2016 Treatment of Drug-Susceptible Tuberculosis Guidelines

Shorter regimens help patients complete treatment faster. Healthcare providers can choose the appropriate TB treatment regimen based on drug-susceptibility results, coexisting medical conditions (e.g., HIV, diabetes), and potential for drug-drug interactions. The State TB Control Offices and TB Centers of Excellence for Training, Education, and Medical Consultation can provide additional assistance and support in treating people with TB disease.